Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for POMGNT2-related limb-girdle muscular dystrophy R24 has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for POMGNT2-related limb-girdle muscular dystrophy R24.
143 publications have been identified in PubMed for POMGNT2-related limb-girdle muscular dystrophy R24. Research spans Review / Meta-Analysis (37%), Basic Science / Preclinical (26%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 53 | 37% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 9:45 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about POMGNT2-related limb-girdle muscular dystrophy R24
Laboratory research |
37 |
26% |
Disease patterns and progression | 22 | 15% |
Testing and diagnosis research | 10 | 7% |
New treatment approaches | 10 | 7% |
Patient case studies | 6 | 4% |
Other research | 4 | 3% |
Clinical study results | 1 | 1% |
Reinhard JR (2026). [PMID: 41635088](https://pubmed.ncbi.nlm.nih.gov/41635088/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Sarde L (2026). [PMID: 41605927](https://pubmed.ncbi.nlm.nih.gov/41605927/). *Nat Commun*. [Diagnostic / Biomarker]
Muelas N (2026). [PMID: 41054283](https://pubmed.ncbi.nlm.nih.gov/41054283/). *Ann Clin Transl Neurol*. [Case Report / Case Series]
Amaro A (2026). [PMID: 41147141](https://pubmed.ncbi.nlm.nih.gov/41147141/). *Brain*. [Basic Science / Preclinical]
Neyaz T (2026). [PMID: 41548516](https://pubmed.ncbi.nlm.nih.gov/41548516/). *Neuromuscul Disord*. [Epidemiology / Natural History]
Vacca O (2026). [PMID: 40734375](https://pubmed.ncbi.nlm.nih.gov/40734375/). *J Neuromuscul Dis*. [Review / Meta-Analysis]
Jaber A (2026). [PMID: 41532585](https://pubmed.ncbi.nlm.nih.gov/41532585/). *Autophagy*. [Gene Therapy / Novel Therapeutics]
Parwez S (2026). [PMID: 41524923](https://pubmed.ncbi.nlm.nih.gov/41524923/). *Mol Biol Rep*. [Review / Meta-Analysis]
Arechavala-Gomeza V (2026). [PMID: 40150900](https://pubmed.ncbi.nlm.nih.gov/40150900/). *J Neuromuscul Dis*. [Review / Meta-Analysis]
Teixeira J (2026). [PMID: 41028318](https://pubmed.ncbi.nlm.nih.gov/41028318/). *Methods Mol Biol*. [Basic Science / Preclinical]